Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 614 results found. Search for [ coronavirus vaccine trials ]

Results 1 to 21 of 614
BusinessToday.In
September 18, 2020
Russian COVID-19 vaccine: Volunteers would receive a second shot of the Russian COVID-19 vaccine within 21 days of the first shot. The adenovirus-based viral vector vaccine is yet to complete a large-scale clinical trial but has been approved by the Russian government


BusinessToday.In
September 18, 2020
Dr Reddy's Laboratories stock touched an all-time high of Rs 5,302 today rising 9.87% against previous close of Rs 4,826 on BSE


Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


BusinessToday.In
September 18, 2020
Kirill Dmitriev, CEO of Russia's sovereign wealth fund Russian Direct Investment Fund, says India will play a vital role in fighting Covid-19 and that government's Make in India initiative has made pharma sector stronger


Reuters
September 18, 2020
The decision by one of the U.N. agency's biggest supporters is a big blow to its strategy aimed at uniting governments around the world to fight the coronavirus pandemic together


BusinessToday.In
September 17, 2020
Dr Reddy's Laboratories stock which closed 4.24% higher in the previous session gained 4.21% or Rs 195 to close at Rs 4,826 on BSE today


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


BusinessToday.In
New Delhi, September 17, 2020
Premium bicycle maker Scott Sports India on Wednesday introduced a full suspension cross country bicycle Spark RC 900 at a whopping Rs 3.7 lakh; Software engineers, physicians, teachers, accountants, analysts, among others are the professionals  who saw the biggest loss of jobs among salaried employees due to coronavirus lockdown; Hyderabad-based Dr Reddy's Laboratories (Dr Reddy's) and Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) have joined hands to carry out clinical trials and distribution of 100 million doses of coronavirus vaccine Sputnik V in India. Watch this and more on News Blast.Also Read: 33% Delhiites exposed to coronavirus, have Covid antibodies, reveals latest sero survey


BusinessToday.In
New Delhi, September 17, 2020
COVID-19 vaccine from Russia! Dr Reddy's ties up with a Russian firm for 100 million dosesHyderabad-based Dr Reddy's Laboratories (Dr Reddy's) and Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) have joined hands to carry out clinical trials and distribution of 100 million doses of coronavirus vaccine Sputnik V in India. Sputnik V vaccine is undergoing final stage clinical trials in Russia. It is also being tested in several other countries. \"Deliveries could potentially...


BusinessToday.In
September 17, 2020
Adar Poonawalla-helmed Serum Institute had partnered with Novavax in August for the production of its coronavirus vaccine. The US drug developer plans to manufacture 2 billion doses annually


Joe C Mathew
September 16, 2020
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India, a joint statement issued by RDIF and Dr Reddy's says


BusinessToday.In
September 16, 2020
Dr Reddy's Lab share touched an intraday high of Rs 4651.95, a rise of 4.7% on BSE


Chitranjan Kumar
September 16, 2020
The Sputnik V vaccine, developed by the Gamaleya research institute in coordination with the Russian defence ministry, is the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


PTI
September 16, 2020
Other ministers who were infected with the pathogen, include Forest Minister Anand Singh, Tourism Minister C T Ravi and Agriculture Minister B C Patil


Rupa Burman Roy
September 16, 2020
Gold, Silver prices today:  On the Multi Commodity Exchange, Gold October Futures gained Rs 166 at Rs 51,935, after hitting an intraday high of Rs 51,943 against the previous close of Rs 51,769 per 10 gm.


Reuters
September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech


BusinessToday.In
September 16, 2020
Besides, the drug regulating body of the country has told the Serum Institute to take extra care during screening, provide additional information in informed consent, and closely monitor participants for any adverse events during follow-up of the study


Reuters
September 16, 2020
In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


PAGES 1 OF 31  12345